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MUTANT SCREEN REPORT
Forward Genetic Screen for Caenorhabditis elegans
Mutants with a Shortened Locomotor Healthspan
Kazuto Kawamura1 and Ichiro N. Maruyama1
Information Processing Biology Unit, Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha,
Onna, Kunigami, Okinawa, Japan, 904-0495
ABSTRACT Two people with the same lifespan do not necessarily have the same healthspan. One person
may retain locomotor and cognitive abilities until the end of life, while another person may lose them during
adulthood. Unbiased searches for genes that are required to maintain locomotor ability during adulthood
may uncover key regulators of locomotor healthspan. Here, we take advantage of the relatively short
lifespan of the nematode Caenorhabditis elegans and develop a novel screening procedure to collect
mutants with locomotor deﬁcits that become apparent in adulthood. After ethyl methanesulfonate muta-
genesis, we isolated ﬁve C. elegans mutant strains that progressively lose adult locomotor ability. In one of
the mutant strains, a nonsense mutation in elpc-2, which encodes Elongator Complex Protein Component
2, causes a progressive decline in locomotor ability during adulthood. Mutants and mutations identiﬁed in
the present screen may provide insights into mechanisms of age-related locomotor impairment and the
maintenance of locomotor healthspan.
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Locomotor ability indicates an animal’s healthspan across many species
such as worms, ﬂies, mice, and humans (Cesari et al. 2009; Grotewiel
et al. 2005; Hahm et al. 2015; Justice et al. 2014). In these species,
declines in locomotor abilities can be a feature of the normal aging
process, or a symptom of an age-related disease. Currently, the genetic
regulators that work to prevent age-related declines in locomotor ability
are largely unknown.
Recent studies have suggested that the genetic bases of lifespan and
healthspan may not completely overlap (Bansal et al. 2015; Iwasa et al.
2010; Tissenbaum 2012). From a candidate-based genetic screen, Iwasa
et al. found that activation of the epidermal growth factor signaling
pathway prolongs adult swimming ability in C. elegans without large
effects on lifespan (Iwasa et al. 2010). More examples of genetic path-
ways that work to maintain locomotor healthspan may be discovered
by carrying out unbiased searches for mutant animals that show pro-
gressive declines in locomotor capacity.
A forward genetic screen using C. elegans has previously been
employed to identify genes that affect locomotor ability during devel-
opment (Brenner 1974). However, unbiased screens that focus on lo-
comotor deﬁcits occurring later in life have not been carried out, in part
due to the difﬁculty in distinguishing whether symptoms observed
during adulthood were already present during development.
In the present study, we established the “Edge Assay” to measure
locomotor ability of hundreds of adult worms at once. Using the Edge
Assay, we developed a screening procedure to remove mutant worms
with strong developmental locomotor defects on the ﬁrst day of adult-
hood, and then isolated mutant worms that progressively lose their lo-
comotor ability on the third or ﬁfth days of adulthood. After ethyl
methanesulfonate (EMS)-mutagenesis, we isolated ﬁve mutant strains
that progressively lose their ability to complete the Edge Assay. In one
mutant strain, we found that a mutation in the elpc-2 gene, encoding
Elongator complex protein component 2, causes progressive loss of lo-
comotor ability. elpc-2 works with other Elongator complex genes, elpc-1
and elpc-3, to maintain adult locomotor ability in C. elegans. Along with
the Elongator complexmutants, isolatedmutants from the present screen
can be used as tools to explore mechanisms that work to maintain adult
locomotor ability in C. elegans, and may provide insights into the evo-
lutionarily conserved regulators of locomotor healthspan.
MATERIALS AND METHODS
Strains
C. elegans Bristol N2 strain was used as wild type. Worms were culti-
vated onNematode GrowthMedia (NGM) agar plates with Escherichia
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coli strain OP50 at 20 (Brenner 1974). Full details of strains used in the
present study are listed in Table S6.
Edge Assay
Edge Assay plates were prepared by pouring 16 ml of NGM agar into a
circular 9 cm plate. NGM plates were dried overnight with the lid on at
25, then kept at 4 until use. On the day before the Edge Assay, a total
of 100ml of E. coli suspensionwas spotted on four spots near the edge of
the NGM plate. The tip of a 50 ml serological pipette was brieﬂy placed
over a ﬂame to smoothen the tip. The NGM plate was placed on an
inoculating turntable and the smoothened pipette tip was held against
the E. coli drop. The plate was slowly rotated while holding the pipette
tip still. The plate was rotated 360 to spread the E. coli around the edge
of the whole plate. Plates were incubated overnight at 25 and used the
next day. Synchronized worms were collected and washed twice with
M9 buffer containing 0.1% gelatin.Worms were placed on the center of
an Edge Assay plate and excessM9 buffer was removedwith the edge of
a Kimwipe. The number of worms that reached or did not reach the
edge were counted at various time points to measure the Edge Assay
completion rate. Floxuridine (FUDR) was not used at any point for
worms tested using the Edge Assay.
Isolation of mutants that show a progressive decline in
locomotor ability
Wild-type N2 worms were mutagenized and cultured as previously
described (Brenner 1974). Larval stage-4 worms were mutagenized
by incubation in a 50 mM EMS solution for 4 h. EMS-mutagenized
F2 adult day 1 worms were collected and washed twice with M9 buffer
containing 0.1% aqueous gelatin. Worms were placed at the center of
an Edge Assay plate and excess buffer was removed with the edge of a
Kimwipe. After 15 min, worms that did not reach the edge were re-
moved using an aspirator. Worms that reached the edge were main-
tained on the same plate until adult day 3. On adult day 3, worms were
collected and washed with M9 buffer containing 0.1% gelatin and the
Edge Assay was repeated on a new Edge Assay plate. Worms that were
unable to reach the edge were collected as adult day 3 progressive
locomotor deﬁcit mutants. Worms that reached the edge were main-
tained on the same plate until adult day 5. On adult day 5, worms were
collected and washed with M9 buffer containing 0.1% gelatin and the
Edge Assay was repeated on a new Edge Assay plate. Worms that were
unable to reach the edge were collected as adult day 5 progressive
locomotor deﬁcit mutants.
Measurements of maximum speed and travel distance
Worms were synchronized by placing ﬁve adult day 1 worms onto an
NGMplatewith food, andallowed to lay eggs for3h.When theoffspring
reached adult day 1, 15wormswere picked randomly onto a 6 cmNGM
plate without bacteria. After the worms moved away from the initial
location with residual food, worms were again moved onto a different
NGM plate without bacteria. Movement of worms was recorded for
1.0 min with a charge-coupled device camera INFINITY3-6URM
(Lumenera Corporation, Ottawa, Canada). Images were analyzed using
ImageJ and wrMTrck software (www.phage.dk/plugins) to produce
maximum speed and travel distance (Nussbaum-Krammer et al.
2015). Measurements were made with the lid on in a temperature-
controlled room set at 20. At least three biological replicate plates of
15 worms each were measured for each strain. Worms that were lost
during the video recording were not included in the analysis. FUDR
was not used at any point for worms subjected to maximum speed and
travel distance measurements.
Lifespan measurements
The lifespan of a population of worms was measured on NGM plates
with food at 20. Worms that did not move after gentle prodding to the
head and tail were counted as dead.Worms that were lost, died from an
exploded vulva, or from the bag-of-worms phenotype were censored.
For the ix243 strain, some worms died from the bag-of-worms pheno-
type. Therefore, we measured lifespan of ix243 and control worms on
plates containing 25 mM FUDR, which is an inhibitor of germline
proliferation. Worms were transferred from NGM plates to FUDR-
containing plates after reaching the L4 stage. All other lifespan mea-
surements were carried out in the absence of FUDR.
Whole-genome DNA sequencing
C. elegans DNA was sequenced using the MiSeq platform (Illumina,
San Diego, CA). Libraries were prepared with an Illumina TruSeq
Library Prep Kit. Mapping was conducted with BWA software (Li
and Durbin 2009). Resulting ﬁles were converted to bam ﬁles, then
to pileup format with Samtools (Li and Durbin, 2009a; Li et al.
2009b). Variant analysis was conducted using VarScan and SnpEff
available on the Galaxy platform (Blankenberg et al. 2010; Cingolani
et al. 2012; Giardine et al. 2005; Goecks et al. 2010; Koboldt et al. 2009).
Mutation frequencies along the chromosome were calculated and vi-
sualized using CloudMap (Minevich et al. 2012).
Transcriptional reporter expression
Agenomic fragment of 2090-bp immediately upstream of the start codon
of the elpc-2 gene was PCR-ampliﬁed using “5’ elpc-2p overlap ppd95.79”
and “3’ elpc-2p overlap ppd95.79” primers, which have 15-bp overhangs
that anneal upstream of the GFP sequence in the pPD95.79 vector
(Primer details are listed in Table S7). The pPD95.79 vector containing
GFP was linearized by PCR using the “5’ ppd95.79” and “3’ ppd95.79”
primers. The template vector was digested with restriction enzymeDpn I
(New England Biolabs, Ipswich, MA), and the linearized vector was
puriﬁed by Wizard SV Gel and PCR Clean-Up System (Promega, Mad-
ison, WI). The pure linearized vector and the elpc-2 promoter were fused
using an In-FusionHDCloningKit (Takara, Kusatsu, Japan) tomake the
elpc-2p::GFP transcriptional reporter construct. The constructwasmicro-
injected into the gonads of wild-type worms at a concentration of 50 ng/
ml. Worms that expressed the reporter construct were immobilized in
25 mM sodium azide and observed under a confocal microscope
LSM710 (Carl Zeiss, Oberkochen, Germany). A z-stack image was cre-
ated from images taken at 1 mm increments.
Creation of double mutants
Doublemutant strains were created by crossingmales of one strainwith
hermaphrodites of another.Doublemutantswere checked by extracting
theirDNA,amplifying agenomic fragmentﬂanking themutation siteby
PCR, and sequencing the PCR product by Sanger sequencing. See
Supplementary Information for primer details.
Statistics
All results are expressed as means with a 95% conﬁdence interval.
Student’s t-test was used for pairwise comparisons with Excel
2010 (Microsoft). For multiple comparisons, one-way ANOVA was
followed with Dunnett’s post hoc test or Tukey’s Honest Signiﬁcant
Difference test using R (Team 2015). Statistical signiﬁcance was set at
P , 0.05; P , 0.01; P , 0.001.
Data availability
All isolated strains and plasmids are available upon request. DNA
sequencing data are available on NCBI Sequence Read Archive:
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PRJNA530333. Supplemental material available at FigShare: https://
doi.org/10.25387/g3.8150759.
RESULTS
The “Edge Assay” can test locomotor ability of
hundreds of worms
The present forward genetic screen isolates mutant worms that pro-
gressively lose locomotor ability. We established the Edge Assay to
measure locomotor ability of hundreds of worms at once. The Edge
Assay is carriedout on a 9-cmagar platewithE. colibacterial feed spread
only on the outer edge of the plate. Up to a few hundred adult worms
are placed on the center of the plate where there is no food (Figure 1A;
Fig. S1). Motile worms reach the E. coli on the edge of the plate, while
worms with defects in locomotion or chemotaxis remain in the center
of the plate.
On the ﬁrst day of adulthood, 91.3% of wild-type worms reached the
edge in15minand99.6%reached the edge in60min (Figure1B; Fig. S1).
C. elegans mutant strains that are defective in the function of neurons,
including unc-13(e51) and unc-43(e408) (Maruyama and Brenner 1991;
Reiner et al. 1999) or muscles such as unc-54(e190) (MacLeod et al.
1981) could not reach the edge in 15 min on the ﬁrst day of adulthood
(Figure 1C). After 60 min, 26% of unc-54(e190) mutants, 6.4% of unc-
43(e408) mutants, and 0% of unc-13(e51) mutants reached the edge
(Figure 1C). Therefore, carrying out the Edge Assay for 15 min on the
ﬁrst day of adulthood can separate wild-type worms from worms with
strong developmental locomotor defects.
On average, over 90% of wild-type worms could complete the Edge
Assay in 60 min during the ﬁrst ﬁve days of adulthood (Figure 1B).
A C. elegans model of amyotrophic lateral sclerosis (SOD1127X)
(Gidalevitz et al. 2009) showed a signiﬁcant reduction in Edge Assay
completion rate compared to that of wild-type worms on the ﬁfth day
of adulthood (Figure 1D). Therefore, carrying out the Edge Assay for
60 min on the ﬁfth day of adulthood can separate wild-type worms
from worms that progressively lose their locomotor ability.
Isolation of mutants that progressively lose locomotor
ability during adulthood
We mutagenized wild-type N2 worms using EMS, and screened
3352 F2 offspring from 500 F1 worms (1000 genomes) (Table S1).
We carried out the Edge Assay for the mutagenized F2 offspring on
the ﬁrst day of adulthood (Figure 2A). To remove worms with devel-
opmental defects, worms that could not complete the Edge Assay in
15 min were aspirated away (Figure 2A). Only worms that completed
the Edge Assay on the ﬁrst day of adulthood were kept for further
screening. On the third and ﬁfth days of adulthood, we tested the
worms again with the Edge Assay and collected slow or uncoordinated
mutants that remained near the center of the Edge Assay plate after
60 min (Figure 2A). By removing worms with strong developmental
defects on the ﬁrst day of adulthood, we were able to isolate worms that
progressively lost locomotor ability during adulthood. We isolated
22 viable mutants, and created individual strains from those mutants
(Table S1). Five of those mutant strains reproducibly showed pro-
gressive deﬁcits in completing the Edge Assay during adulthood
(Figure 2B).
To determine whether isolated mutant strains have deﬁcits in
locomotor ability and not sensory function or search behavior, we
measured locomotor ability of worms on an agar plate without food.
We recorded one-minute videos of 15 worms freely moving on a plate,
andmeasured themaximumvelocities and total travel distances for each
worm. For each strain, we recorded three plates of 15worms on the ﬁrst,
third, and ﬁfth days of adulthood. All isolated mutant strains showed
signiﬁcantly greater reductions inmaximumvelocity and travel distance
from the ﬁrst toﬁfth days of adulthood compared towild type except for
ix240 worms (Figure 3A, 3B, 3D; Fig. S2A–S2D, S3A–S3D). In the
ix240 worms, progressive deﬁcits other than locomotor ability, such
as sensory function or search behavior,may cause the reduction in Edge
Assay completion rate.
ix241 and ix243 mutant strains show progressive
decline in locomotor ability
ix241 and ix243worms were backcrossed with the parental N2 strain to
reduce the number of mutation sites that do not affect locomotor
ability. After each backcross, we checked for individual lines that still
showed a progressive decline in locomotor ability. We measured the
maximum velocity and travel distance of individual worms on an agar
Figure 1 “Edge Assay” can measure locomotor ability of worms (A)
(Left) Schematic diagram of an Edge Assay plate immediately after
placing worms at the center of the plate. (Right) Schematic diagram
of Edge Assay plate after most worms reached the edge. (B) Edge
Assay completion rates of wild-type worms from adult day 1 to 7 after
5, 10, 15, 30, and 60 min. (C) Completion rates for WT and devel-
opmental mutants deﬁcient in locomotor function, unc-54(e190),
unc-43(e408), and unc-13(e51). (D) Completion rates of WT and a
previously reported C. elegans model of amyotrophic lateral sclero-
sis (SOD1127X). For Edge Assay experiments, n = 3 biological repli-
cate plates with each plate starting with approximately 100 worms
per plate on adult day 1. Error bars indicate 95% conﬁdence inter-
vals. P , 0.05; Unpaired Student’s t-test.
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plate without food on the ﬁrst, third, and ﬁfth days of adulthood. ix241
and ix243 worms still showed signiﬁcant reductions in both maximum
velocity and travel distance after the fourth backcross (Figure 3A, 3B,
3D; Fig. S3A–S3D).
To check whether ix241 and ix243 worms were simply aging
faster than wild-type worms, we measured lifespans of the two
strains. The lifespan of ix241 worms was not signiﬁcantly shortened
compared to that of wild type (Figure 3E; Table S2). The median
lifespan of the ix243 worms was shortened by two days (Figure 3C;
Table S2). To compare relative reductions in lifespan and locomotor
healthspan, we measured the maximum velocities of wild type and
ix243 worms for 10 days (Fig. S4A). We quantiﬁed the percent de-
crease in lifespan by comparing the areas under the survival curves
of wild type and ix243 worms (Fig. S4B). We quantiﬁed the percent
decrease in locomotor healthspan by comparing the areas under the
decline in maximum velocity curves of wild type and ix243 worms
(Fig. S4C). For ix243 worms, there is an average 11.5% reduction in
lifespan, while there is a signiﬁcantly greater 18.5% reduction in
locomotor healthspan (Fig. S4D).
ix243 worms take a 13.9% longer time to reach adulthood (Table
S3). The developmental delay was taken into account for locomotor
and lifespan measurements by allowing ix243 worms an extra 10 h to
develop, and starting locomotor and lifespan measurements from the
ﬁrst day of adulthood. ix243 worms show a 17.7% decrease in maxi-
mum locomotor ability on the ﬁrst day of adulthood compared to wild-
type worms (Figure 3B). The deﬁcit in locomotor ability compared to
wild-type worms increases to 54.8% on the ﬁfth day of adulthood
(Figure 3B). These results suggest that the ix243 mutant allele has
modest negative effects on development and lifespan, with relatively
stronger negative effects on locomotor healthspan.
ix241 worms take 4.0% longer to reach adulthood (Table S3) and
show an 18.1% decrease in maximum locomotor ability on the ﬁrst day
of adulthood compared to wild-type worms (Figure 3D). The deﬁcit in
locomotor ability compared to wild-type worms increases to 43.0% on
the ﬁfth day of adulthood (Figure 3D). The ix241mutant allele has no
negative effect on lifespan, a modest negative effect on development,
and a relatively stronger negative effect on locomotor healthspan.
Nonsense mutation in elpc-2 causes progressive loss of
adult locomotor ability in ix243 worms
Weusedwhole genomesequencingand amodiﬁedversion of the sibling
subtraction method to identify the causative mutation site in the ix243
strain (Fig. S5) (Joseph et al. 2018). Mutations were evenly induced
on all chromosomes in the ix243 mutant strain before backcrossing
(Figure 4A). Manymutations remained on Chromosome III after com-
paring mutations in backcrossed strains that show a progressive loss of
adult locomotor ability and subtracting mutations in backcrossed
strains that do not show progressive loss of adult locomotor ability
(Figure 4B; Table S4). A nonsense mutation from TGG to TAG within
the protein coding region of elpc-2 was predicted to disrupt protein
function (Figure 4C; Table S4). Presence of the elpc-2mutation site was
conﬁrmed by Sanger sequencing (Figure 4D).
To test whether loss of elpc-2 causes a progressive decline in loco-
motor ability, we injected a genomic fragment of elpc-2 including 2090-
base pairs (bp) upstream of the start codon and 851-bp downstream of
the stop codon in the ix243 mutant strain. The wild-type elpc-2 frag-
ment rescued the progressive loss of adult locomotor ability (Figure 4E,
4F; Fig. S6A, B). These results suggest that elpc-2 is required for main-
tenance of adult locomotor ability in C. elegans. The ix243 mutant
strain is the ﬁrst reported mutant of the elpc-2 gene in C. elegans.
The Elongator complex is required to maintain
locomotor ability
ELPC-2 is a component of the Elongator complex. InC. elegans, there are
four predicted components of the Elongator complex (ELPC1–4)
(Solinger et al. 2010). To test whether functional loss of elpc-2 causes
the locomotor defect independently or as part of the Elongator complex,
we measured locomotor ability of strains carrying deletions in elpc-1 and
elpc-3. We found that elpc-1(tm2149) and elpc-3(ok2452) mutant strains
also cannot maintain locomotor ability during adulthood (Figures 5A,
5B). elpc-1(tm2149);elpc-2(ix243) and elpc-2(ix243);elpc-3(ok2452) double
mutants did not show additive deﬁciencies in locomotor ability (Figure
5C; Fig. S7A–H). These results suggest that proper functioning of the
entire Elongator complex is necessary tomaintain locomotor healthspan.
We assessed the expression pattern of elpc-2 by creating an elpc-2p::GFP
transcriptional reporter that expresses GFP under control of the elpc-2
promoter. The transcriptional reporter was broadly expressed in many
tissues including head and body wall muscles, head neurons, pharynx,
canal cell, coelomocytes, intestine, and tail (Fig. S8A–C). The expression
Figure 2 Isolation of mutant strains that progressively lose locomotor
ability (A) Schematic description of a forward genetic screen to isolate
mutants that progressively lose locomotor ability. (B) Edge Assay
completion rates of mutants identiﬁed from the screen. Error bars
indicate 95% conﬁdence intervals. n = 3 biological replicate plates,
with each plate starting with approximately one hundred worms per
plate on adult day 1. P , 0.05; P , 0.01; ns, not signiﬁcant; Paired
Student’s t-test vs. adult day 1 completion rate.
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pattern of elpc-2 overlaps with previously reported expression of elpc-1 in
the pharynx, head neurons, and body wall muscles (Chen et al. 2009a).
Loss-of-function mutation in tut-1 also causes
progressive decline in locomotor ability
Mutants for elpc-1 and elpc-3 have previously been reported to modify
the wobble uridine (U34) of tRNA by adding carbamoylmethyl (ncm)
and methoxycarbonylmethyl (mcm) side chains to the 59carbon of U34
(Chen et al. 2009a; Nedialkova and Leidel 2015). Wobble uridines with
the mcm5 modiﬁcation are further modiﬁed by TUT-1 to add a thio-
group at the 2’ carbon to create mcm5s2U (Chen et al. 2009a). In wild-
type worms, only ncm5 and mcm5s2 modiﬁcations are present (Chen
et al. 2009a). In tut-1(tm1297) mutants, an mcm5 modiﬁcation was
observed, which is not normally present in wild-type worms (Chen
et al. 2009a). In elpc mutants, an s2 modiﬁcation was observed, which
is not normally present in wild-type worms (Chen et al. 2009a).
To check whether loss of tRNA thiolation could cause a progressive
decline in locomotor function, we measured the locomotor ability of
tut-1(tm1297)mutant worms. tut-1(tm1297)mutant worms showed
a signiﬁcantly greater decline in locomotor ability during adulthood
compared to wild-type worms, indicating that tRNA modiﬁcations
may be a general mechanism involved in maintenance of locomotor
healthspan in C. elegans (Figure 6A; Fig. S9A, B).
The elpc-2(ix243);tut-1(tm1297) double mutant showed synthetic
effects for locomotor ability and for developmental maturation. elpc-
2(ix243);tut-1(tm1297) doublemutant worms showed a strong defect in
locomotor ability on the ﬁrst day of adulthood and a signiﬁcantly
greater reduction in maximum velocity and travel distance during
adulthood relative to either of the single mutants (Figure 6A; Fig.
S9A, B). In addition, elpc-2(ix243);tut-1(tm1297) doublemutant worms
took almost twice as long to reach adulthood (145.4 h) compared to
elpc-2(ix243) worms (80.2 h) or tut-1(tm1297) worms (82.0 h) (Tables
S3 and S5). The synthetic effects may be explained by the complete
absence of U34 modiﬁcations in the elpc-2(ix243);tut-1(tm1297) double
mutant strain. The presence of the s2 modiﬁcation in the elpcmutants,
and the presence of the mcm5 and ncm5 modiﬁcations in the tut-1
mutant may enable partial tRNA functionality and allow relatively
proper development and partial capacities to maintain locomotor abil-
ity (Figure 6B).
DISCUSSION
In this study, we established the Edge Assay to simultaneously measure
locomotor ability of up to a few hundred adult worms. For the present
forward genetic screen, we used the Edge Assay to remove worms with
strong developmental locomotor defects, and isolated worms with
locomotor deﬁcits that become apparent in adulthood. By carrying
out the EdgeAssay on the ﬁrst day of adulthood,wewere able to remove
worms with strong developmental locomotor defects and overcome the
difﬁculty of distinguishing developmental and progressive locomotor
deﬁcit mutants.
The Edge Assay may be used for a variety of applications involving
locomotorability. Forexample, theEdgeAssaycanbeused in suppressor
screens to search for mutant worms that show improvements in
locomotor ability of previously characterized C. elegansmodels of neu-
rodegenerative disease. It may also be possible to use the Edge Assay to
screen for other types of progressive declines in functional capacity
such as sensory or cognitive deﬁcits by replacing the food ring with
speciﬁc chemicals or learned cues.
The ix241 and ix243 mutant strains show similar declines in loco-
motor ability, but have different phenotypes in regard to lifespan. This
suggests that genes that regulate lifespan and locomotor healthspan
may not completely overlap. In terms of improving quality of life, ge-
netic regulators of healthspan may be better therapeutic targets than
regulators of lifespan. Further studies and genetic screens that focus on
healthspan-related phenotypes may provide novel insights into mech-
anisms that regulate healthspan and quality of life across many species.
In the ix243 mutant strain, we found that elpc-2 is required to
maintain locomotor healthspan, and works as part of the Elongator
complex. The Elongator complex is an evolutionarily conserved protein
complex that consists of six subunits in Saccharomyces cerevisiae,
Figure 3 ix241 and ix243 worms
show progressive locomotor de-
cline after four backcrosses (A)
Representative locomotor tracks
from 1-min video recordings of
WT, ix243 backcrossed four times
(4x BC), and ix241(4x BC) on
adult days 1, 3, and 5 on plates
with no food. n = 10–15 tracks
per plate (some worms were
unable to be tracked for a full
minute, and were removed from
analysis) (B) (Left) Maximum ve-
locities of WT and ix243(4x BC)
worms. (Right) Percent change in
maximum velocity of WT and
ix243(4x BC) worms on adult day
5 compared to adult day 1. (C)
Survival curve ofWT (n= 56) worms
and ix243(4x BC) (n = 89) worms.
(D) (Left) Maximum velocities of
WT and ix241(4x BC) worms. (Right) Change in maximum velocity of WT and ix241(4x BC) worms. (E) Survival curve of WT (n = 94) and ix241(4x
BC) (n = 77) worms. Error bars indicate 95% conﬁdence intervals. For maximum velocity experiments, n = 30–45 worms per strain for each day (10–
15 worms from 3 biological replicate plates). For percent change in maximum velocity graphs, n = 3 biological replicate plates. P , 0.001; ns,
not signiﬁcant; Unpaired Student’s t-test for maximum velocity comparisons; Log-rank test for lifespan comparisons.
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Arabidopsis thaliana,Mus musculus, and humans (Creppe and Busch-
beck 2011; Dauden et al. 2017). ELP1–ELP3 form the core complex,
and ELP4–ELP6 form a sub-complex (Creppe and Buschbeck 2011). In
C. elegans, there are currently only four predicted homologs of the
Elongator complex (elpc-1–4). From the present study, loss-of-function
mutations in elpc-1, elpc-2, and elpc-3 caused a shortened locomotor
healthspan. Proper functioning of the Elongator complex may require
multiple or all components of the complex (Dauden et al. 2017). The
present work suggests that the Elongator complex is essential in main-
tenance of locomotor healthspan.
Allelic variants of ELP3, the catalytic subunit of the Elongator
complex, were found to be associated with amyotrophic lateral sclerosis
(ALS) in three human populations (Simpson et al. 2009). Risk-associ-
ated alleles have lower levels of ELP3 in the cerebellum and motor
cortex of ALS patients, and protection-associated alleles have higher
levels of ELP3 (Simpson et al. 2009). Overexpression of ELP3 reduced
levels of axonopathy in the SOD1A4V zebraﬁsh model of ALS and
SOD1G93A mousemodel of ALS (Bento-Abreu et al. 2018). The present
work complements studies that have been performed in the context of
ALS, and suggests that loss of the Elongator complex alone can cause
locomotor deﬁcits during adulthood inC. elegans. Future therapies that
target multiple subunits of the Elongator complex may provide more
robust effects than therapies that target only the catalytic ELP3 subunit.
ELP2 mutations were reported as the causative mutations in a
familial form of neurodevelopmental disability (Cohen et al. 2015).
Patients who are compound heterozygotes for two different ELP2 mis-
sense mutations demonstrate a lack of motor control starting in early
development, severe intellectual disability, and progressive loss of loco-
motor function (Cohen et al. 2015). In our newly isolated elpc-2(ix243)
strain, we also see deﬁcits in locomotor function on the ﬁrst day of
adulthood and a delay in development (Figure 3A, 3B; Fig. S3A, S3B;
Table S3). Since the amino acid sequences of C. elegans ELPC-2 and
human ELP2 are highly conserved (Fig. S10) (Sievers et al. 2011), some
aspects of the neurodevelopmental dysfunctions that result from the hu-
man ELP2 mutation may be modeled in our elpc-2(ix243)mutant strain.
Mutations in ELP1 and ELP4 are also implicated with neuronal
disorders. ELP1 is associated with familial dysautonomia, a neuro-
developmental disorder that affects the sensory and autonomic nervous
system (Rubin and Anderson 2017). ELP4 is implicated in rolandic
epilepsy, which is characterized by seizures that affect the vocal tract
(Strug et al. 2009). Mutations in ELP1–4 all affect nervous system
function, suggesting the importance of the Elongator complex in the
development andmaintenance of neurons. However, mutations in each
ELP subunit cause different symptoms, suggesting that ELP subunits
may have additional roles speciﬁc to neuronal subtype. Mice with
complete loss of ELP1 or ELP3 are not viable (Chen et al. 2009b;
Yoo et al. 2016), so it may be difﬁcult to study the roles of each ELP
subunit inmice. SinceC. elegans ELPmutants are viable, it may provide
an opportunity to explore the different functions of each ELP subunit.
Figure 4 elpc-2 mutation causes locomotor deﬁcits in the ix243 mu-
tant strain (A) Mutation frequency along each chromosome of ix243
mutant strain before backcrossing. Red bars indicate 0.5-Mb bins and
gray bars indicate 1.0-Mb bins. (B) Mutation frequency along each
chromosome for pooled ix243(4x BC) worms. (C) Schematic diagram
of ELPC-2 protein and location of mutation site in ix243 allele. (D)
ix243 mutation site on ELPC-2 amino acid (AA) sequence and elpc-2
DNA sequence. (E) Representative locomotor tracks of WT, ix243(4x
BC), and ix243(4x BC);Ex[elpc-2(+)] #1 worms. (F) (Left) Maximum ve-
locities of WT, ix243(4x BC), ix243(4x BC);Ex[elpc-2(+)] #1, and
ix243(4x BC);Ex[elpc-2(+)] #2 worms. n = 30–45 worms per strain for
each day (10–15 worms from 3 biological replicate plates). (Right)
Percent change in maximum velocity of worms from left panel. n =
3 biological replicate plates. Error bars indicate 95% conﬁdence inter-
vals. P , 0.01; ns, not signiﬁcant; One-way ANOVA with Dunnett’s
post hoc test vs. WT.
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The Elongator complex was originally identiﬁed as a transcriptional
regulator associated with RNA polymerase II (Otero et al. 1999). How-
ever, follow-up studies have found that the main functions of the Elon-
gator complex may involve tRNA modiﬁcation (Chen et al. 2009a;
Huang et al. 2005), and tubulin acetylation (Solinger et al. 2010). The
tRNA thiolation mutant, tut-1(tm1297), also showed a progressive de-
cline in locomotor function. Since tRNA modiﬁcations are important
for proper translation and folding of proteins in yeast (Nedialkova and
Leidel 2015), it may affect locomotor healthspan by regulating trans-
lation efﬁciency and protein folding in other organisms including
C. elegans and humans.
C. elegans loses production of molecular chaperones at an early
stage of adulthood (Ben-Zvi et al. 2009). Therefore, misfolded proteins
that are produced by inefﬁcient tRNA modiﬁcations may begin to
accumulate during early adulthood and cause a progressive decline in
locomotor ability. Regulation of proper tRNA modiﬁcations during
Figure 5 The Elongator complex is required to maintain locomotor
ability (A) Representative locomotor tracks of WT, elpc-1(tm2149) and
elpc-3(ok2452) worms. n = 10–15 tracks per plate. (B) (Left) Maximum
velocities of WT, elpc-1(tm2149), and elpc-3(ok2452) worms. (Right)
Percent change in maximum velocity of worms from left panel. (C)
(Left) Maximum velocities of WT, elpc-2(ix243), elpc-3(ok2452), and
elpc-2(ix243);elpc-3(ok2452) worms. (Right) Percent change in maxi-
mum velocity of worms from left panel. Error bars indicate 95% con-
ﬁdence intervals. For maximum velocity experiments, n = 30–45
worms per strain for each day (10–15 worms from 3 biological replicate
plates). For percent change in maximum velocity graphs, n = 3 biolog-
ical replicate plates. P, 0.001; ns, not signiﬁcant; One-way ANOVA
with Dunnett’s post hoc test vs. WT for B; One-way ANOVA with
Tukey’s post hoc test for C.
Figure 6 tut-1(tm1297) mutant shows progressive decline in locomo-
tor ability (A) (Left) Maximum velocities of WT, elpc-2(ix243), tut-
1(tm1297), and elpc-2(ix243);tut-1(tm1297) worms. (Right) Percent
change in maximum velocity of worms from left panel. Error bars in-
dicate 95% conﬁdence intervals. n = 30–45 worms per strain for each
day (10–15 worms from 3 biological replicate plates). For percent
change in maximum velocity graphs, n = 3 biological replicate plates.
P , 0.05; P , 0.001; ns, not signiﬁcant; One-way ANOVA with
Tukey’s post hoc test. (B) Summary of observed tRNA modiﬁcations
in elpc and tut-1 mutants from Chen et al. (2009b), and summary of
observed phenotypes in elpc and tut-1 mutants from this study.
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aging may represent a new avenue to promote proteostasis and loco-
motor healthspan.
Starting from an unbiased forward genetic screen using C. elegans,
we found that mutations in Elongator complex and tut-1 cause pro-
gressive declines in locomotor ability during adulthood. Future screen-
ing procedures that utilize the Edge Assay, and further analysis of the
isolatedmutants from the present screenmay provide insights into how
locomotor ability is maintained during adulthood.
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